Amgen's revenue grows 8% and adjusted profit beats expectations
Amgen earned $6.45 per share in the third quarter on an adjusted basis, which leaves out some costs and gains. Analysts expected $5.91. Total revenues rose 8% to $10.4 billion, and the company says higher sales volumes drove its product sales growth.
The results
Q3 2026
+9.2%
Adj. earnings
+0.9%
Revenue
+3.7%
The stock
Adjusted earnings per share
Expected $5.91
$6.45
Revenue
Expected $10.27B
$10.37B
What the company expects
For full-year 2026, Amgen expects total revenues of $38.9 billion to $39.7 billion and adjusted earnings per share of $22.90 to $23.70, or $18.34 to $19.28 under standard accounting rules. It plans about $2.6 billion of capital spending and share buybacks of no more than $3.0 billion.
Results for Q3 2026, released on November 3, after the close. Expected: average of analysts' forecasts. Earnings per share under GAAP accounting rules: $7.08.
Who holds it
AI analysis
Nov 3
With TrueWallet Pro
What drove the quarter, what it changes for the stock, and what it does not say. Upgrade to Pro from the TrueWallet app.